4/A//SEC Filing
DelMar Pharmaceuticals, Inc. 4/A
Accession 0001013762-14-001273
$HURACIK 0001498382operating
Filed
Oct 30, 8:00 PM ET
Accepted
Oct 31, 9:38 PM ET
Size
5.8 KB
Accession
0001013762-14-001273
Insider Transaction Report
Form 4/AAmended
Garner William J
Director
Transactions
- Conversion
Exchangeable Shares
2014-03-18−80,000→ 2,438,541 total(indirect: See Footnote)→ Common Stock (80,000 underlying)
Footnotes (2)
- [F1]Exchangeable Shares are shares of Exchangeco (as that term is defined in the Issuer's Current Report on Form 8-K filed with the SEC on January 31, 2013) which are exchangeable on a 1-for-1 basis for shares of common stock in the Issuer at any time at the discretion of the Reporting Person. This Form 4/A amends the Form 4 filed by the Reporting Person on March 20, 2014 solely to amend the disclosure of the Exchangeable Shares beneficially owned as of such date by the Reporting Person.
- [F2]Shares are held in trust by Jeffrey Bacha.
Documents
Issuer
DelMar Pharmaceuticals, Inc.
CIK 0001498382
Entity typeoperating
IncorporatedNV
Related Parties
1- filerCIK 0001498382
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 30, 8:00 PM ET
- Accepted
- Oct 31, 9:38 PM ET
- Size
- 5.8 KB